Shiv Sena leader Sushil Kumar Jain relinquishes Hindutva, embraces Islam

Bengaluru, May 23: It was a stampede-like situation near Palace Grounds in Bengaluru on Saturday afternoon. The incident took place after hundreds of migrants gathered and jostled to gain entry. The situation raises concerns as no social distancing norms were followed.

According to Chetan Singh Rathore, DCP Central, the reason behind the stampede-like situation was an en masse message. "What we heard was that an en masse message has been conveyed to the people of Manipur and Odisha that they would be able to go home on trains on Saturday. The message did not consider the capacity of the train which is only 1500 seating capacity for Manipur train and 1500 for Odisha train," he told media.

Singh further added, "But the people gathered were around 3000 in number for the Manipur train and 5000 for the Odisha train. Passengers with tickets and requisites were allowed to travel while others were asked to return home and wait for their turn to travel back home."

The state of Karnataka has eased lockdown restrictions across, allowing state transport services to run. Lately, the government has been running special Shramik trains from Karnataka to ferry migrant workers back to their hometowns.

Mangaluru, June 11: The private flight chartered by Saudi Arabia's SAQCO Contracting Company to repatriate coastal Kannadigas stranded in the kingdom landed at Mangaluru International Airport at 1:15 am on Wednesday.

The flight with 175 passengers took off from the Dammam International Airport around 6 pm (KSA time).

SAQCO’s Directors Althaf Ullal and Basheer Sagar said that all the legal procedures were carried out smoothly before the flight took off from Dammam for Mangaluru.

The duo also informed that no staff or official of SAQCO were traveling on the chartered flight and that it was arranged only for the stranded Kannadigas. The cost of traveling, institutional quarantine, and COVID-19 tests will be borne by the SAQCO Company.

SAQCO had established a desk to finalize the list of passengers who will be traveling on the flight to Mangaluru on Wednesday. The company added priority was given to pregnant women, the senior citizens who had come to the kingdom on visit visas, people with medical emergencies, people who had lost jobs, and those who had reported deaths in their families.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.